Filing Details

Accession Number:
0001883850-23-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-27 16:37:48
Reporting Period:
2023-03-23
Accepted Time:
2023-03-27 16:37:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697422 R. Christopher Fenimore 777 Old Saw Mill River Road
Tarrytown NY 10591
Svp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-23 2,192 $806.47 18,409 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,473 Indirect 2021 GRAT
Common Stock 5,000 Indirect 2022 GRAT
Common Stock 1,480 Indirect By 401(k) Plan
Common Stock 1,897 Indirect By Trust
Common Stock 461 Indirect by Trust for Daugh
Common Stock 460 Indirect by Trust for Son
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 9, 2023.
  2. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.